Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy for beginners now. On June 11, Eli Lilly announced a ...

The Department of Health and Human Services is allegedly denying clinical trial funding for biotechs based on their ties to ...

A clinical-stage biotech company based in Redwood City, California, developing tissue-restorative biologics for chronic ...

California-based clinical-stage biotech Juvena Therapeutics has entered a global licensing and multi-target research ...

Eli Lilly (NYSE:LLY) recently saw its stock price rise by 6.63% over the last month, a movement potentially influenced by ...

Juvena Therapeutics & Eli Lilly and Company ink research collaboration focused on muscle health: Redwood City, California Saturday, June 14, 2025, 15:00 Hrs [IST] Juvena Therapeut ...

On June 11, Eli Lilly announced a partnership with Juvena Therapeutics to develop new muscle-boosting drugs. The collaboration is valued at over $650 million, with the majority of this sum tied to ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Alector said it promoted Business Chief Neil Berkley as interim chief financial officer. Berkeley will succeed Marc Grasso, who gave notice of his decision to resign from the position to pursue ...

Before joining Alector, he served as Chief Corporate Development Officer at Juvena Therapeutics, Chief Business Officer at AbCellera, and Vice President and Head of Business Development at ...